| Acute elevation of plasma non-esterified fatty acids increases pulse wave velocity and induces peripheral vasodilation in humans in vivo. | |
| | |
MedLine Citation:
|
PMID: 17309447 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Plasma NEFA (non-esterified fatty acid) concentrations are elevated in patients with obesity. In the present study we first aimed to provide an integral haemodynamic profile of elevated plasma NEFAs by the simultaneous assessment of blood pressure, pulse wave velocity, FBF (forearm blood flow) and sympathetic nervous system activity during acute elevation of NEFAs. Secondly, we hypothesized that NEFA-induced vasodilation is mediated by adenosine receptor stimulation. In a randomized cross-over trial in healthy subjects, Intralipid was infused for 2 h to elevate plasma NEFAs. Glycerol was administered as the Control infusion. We assessed blood pressure, pulse wave velocity, FBF (using venous occlusion plethysmography) and sympathetic nervous system activity by measurement of noradrenaline and adrenaline. During the last 15 min of Intralipid/Control infusion, the adenosine receptor antagonist caffeine (90 microg x min(-1) x dl(-1)) was administered into the brachial artery of the non-dominant arm. Compared with Control infusion, Intralipid increased pulse wave velocity, SBP (systolic blood pressure) and pulse pressure, as well as FBF (from 1.8+/-0.2 to 2.7+/-0.6 and from 2.3+/-0.2 to 2.7+/-0.6 ml x min(-1) x dl(-1) for Intralipid compared with Control infusion; P<0.05, n=9). Although in a positive control study caffeine attenuated adenosine-induced forearm vasodilation (P<0.01, n=6), caffeine had no effect on Intralipid-induced vasodilation (P=0.5). In conclusion, elevation of plasma NEFA levels increased pulse wave velocity, SBP and pulse pressure. FBF was also increased, either by baroreflex-mediated inhibition of the sympathetic nervous system or by a direct vasodilating effect of NEFAs. As the adenosine receptor antagonist caffeine could not antagonize the vasodilator response, this response is not mediated by adenosine receptor stimulation. |
| | |
Authors:
|
Niels P Riksen; Marlies Bosselaar; Stephan J L Bakker; Robert J Heine; Gerard A Rongen; Cees J Tack; Paul Smits |
Related Documents
:
|
557057 - Analysis by high-pressure liquid chromatography of 9-beta-d-arabinofuranosyladenine 5'-... 2590907 - Mechanism of the apparent parasympathetic inhibition of adenosine induced heart rate sl... 8452257 - Vasodilation with adenosine or sodium nitroprusside after coronary artery bypass surger... 3663447 - Circulatory and respiratory effects of infused adenosine in conscious man. 18036367 - Relation of optimal lead positioning as defined by three-dimensional echocardiography t... 12765887 - Left ventricular regional wall motion abnormalities during pneumoperitoneum in children. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Clinical science (London, England : 1979) Volume: 113 ISSN: 1470-8736 ISO Abbreviation: Clin. Sci. Publication Date: 2007 Jul |
Date Detail:
|
Created Date: 2007-05-31 Completed Date: 2007-06-27 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7905731 Medline TA: Clin Sci (Lond) Country: England |
Other Details:
|
Languages: eng Pagination: 33-40 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology-Toxicology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. N.Riksen@aig.umcn.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenosine
/
pharmacology* Autonomic Nervous System Blood Flow Velocity / drug effects Blood Pressure / drug effects Caffeine / pharmacokinetics Compliance Cross-Over Studies Fat Emulsions, Intravenous / pharmacology Fatty Acids, Unsaturated / metabolism* Forearm / blood supply* Humans Insulin / blood Pulse Receptors, Purinergic P1 / drug effects Vasodilation / drug effects Vasodilator Agents / pharmacology* |
| Chemical | |
Reg. No./Substance:
|
0/Fat Emulsions, Intravenous; 0/Fatty Acids, Unsaturated; 0/Receptors, Purinergic P1; 0/Vasodilator Agents; 11061-68-0/Insulin; 58-08-2/Caffeine; 58-61-7/Adenosine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Functional domains and interdomain communication in Candida albicans glucosamine-6-phosphate synthas...
Next Document: Evolution of the 12 kDa FK506-binding protein gene.